Skip NavigationFMCSA Home U.S. Department of Transportation Contact NRCME  

National Registry of Certified Medical Examiners

Federal Motor Carrier Safety Administration

Home About Meetings & Conferences Training & Certification Medical Examiners CMV Drivers & Motor Carriers Rules & Regulations
 

Conditions and Treatments

Vision - 49 CFR 391.41(b)(10)

Ophthalmic Preparations

Determine if the treatment is having the desired effect of preserving vision that meets qualification requirements without any visual and/or systemic side effects that interfere with safe driving (e.g., stinging, blurring, decreased night vision, sensitivity to glare, headache, or allergic reaction).

Categories include:

Classifications of agents used to treat age-related macular degeneration include:

  • Antioxidants and zinc.
  • Vascular endothelial growth factor (VEGF) inhibitors.

Classifications of anti-allergy agents used to treat allergic conjunctivitis include:

  • Oral and topical antihistamines.
  • Topical decongestants.
  • Antihistamine/decongestant combinations.
  • Mast cell stabilizers.
  • Topical nonsteroidal anti-inflammatory.

Classifications of agents used to treat glaucoma include:

  • Prostaglandin analogs.
  • Beta adrenergic blocking agents.
  • Carbonic anhydrase inhibitors.
  • Alpha agonists.
  • Cholinergic agonists.
  • Osmotic agents.
  • Combinations.

Classifications of anti-infective agents used to treat bacterial conjunctivitis include oral and topical antibiotics.

Classifications of agents used to treat dry eyes include:

  • Lubricants.
  • Nonsteroidal anti-inflammatory.
  • Topical cyclosporine.
Go To Top of Page